Share Twitter LinkedIn Facebook Email John Strickler, M.D. Assistant Professor Of Medicine At Duke Cancer Institute, Discusses KEYNOTE-181 Esophageal Cancer Study. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com
SGNTUC-024 Phase 1b/2 study: Tucatinib, trastuzumab, FOLFOX for HER2+ GI cancers Gastrointestinal 8 Mins Read